Abstract:Determining the presence of paraquat (PQ) and diquat (DQ) in urine samples through physical and chemical testing is challenging. As PQ and DQ have characteristics such as high molecular polarity and good water solubility, they are difficult to be retained by conventional reversed-phase columns. Most of the methods in the literature use hydrophilic interaction chromatography (HILIC) for the retention of PQ and DQ, but they often require high concentrations of buffer salts as the mobile phase, which increase the contamination of the mass spectrometer. In view of the above problems, a rapid and accurate analysis method was developed for the determination of PQ and DQ residuals in urine samples based on weak cation exchange (WCX) solid-phase extraction (SPE) and ultra performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) in this study. Urine samples were first diluted with phosphate buffer (pH=6.86) and pretreated using the WCX SPE method. Chromatographic separation was performed on a Syncronis HILIC column (100 mm×2.1 mm, 1.7 μm). An electrospray ion source in the positive (ESI+) mode and full mass-data dependent MS2 (full mass-ddMS2) mode was used for quantification by matrix-matched external standard method. In this study, the concentration of ammonium formate in the mobile phase in the HILIC mode was effectively reduced to 10 mmol/L by the continuous optimization of the chromatographic conditions. MS optimization results indicated that the molecular ion (M+·) of PQ and DQ had the strongest response. In addition, sample pretreatment conditions were also optimized. The obtained results indicated that the hydrophobic polytetrafluoroethylene (PTFE) filter membrane, acetonitrile-water (1∶1, v/v) as a fixing solution, and polypropylene vials were suitable for PQ and DQ analysis. Under the optimal conditions, the linearity of PQ and DQ was good with correlation coefficients (r2) greater than 0.998. The limits of detection (LODs, S/N≥3) and limits of quantification (LOQs, S/N≥10) were 0.2 μg/L and 0.6 μg/L, respectively. Mean spiked recoveries of PQ and DQ at the four spiked levels (1.0, 20.0, 100.0, and 200.0 μg/L) were in the range of 85.8%-101% and 80.3%-86.9%, with the RSDs of 0.8%-5.1% and 0.9%-4.2%. The established method was employed for the analysis and confirmation of PQ and DQ for clinical poisoning cases. In one case, a 23-year-old male who had taken approximately 20 mL of pesticide orally was confirmed as DQ poisoning by the developed method. DQ concentration monitoring of the urine samples was conducted for this case during the clinical treatment process. The patient was successfully discharged from the hospital after five times of blood perfusion and other treatments until the DQ concentration was low in the urine samples. In conclusion, the method developed in this study based on WCX SPE-UPLC-HRMS can be used for the confirmation of poisoning cases and concentration monitoring during clinical treatment, providing strong technical support for clinical precision treatment. The method is rapid, simple, sensitive, and accurate, and it is suitable for the detection of PQ and DQ in urine samples.

Determination of Paraquat in Plasma by Reversed Phase Ion-pair HPLC

Determination of Paraquat in Human Serum by HPLC

Fast Determination of Paraquat in Plasma and Urine Samples by Solid-Phase Microextraction and Gas Chromatography–mass Spectrometry

Simultaneous determination of paraquat and diquat in human plasma by HPLC‐DAD: Its application in acute poisoning patients induced by these two herbicides

A Novel Approach for Determination of Paraquat Based on Dried Blood Spot (DBS) Extraction and UHPLC-HRMS Analysis.

Determination of Paraquat in Vegetables Using HPLC-MS-MS

Quantification and toxicokinetics of paraquat in mouse plasma and lung tissues by internal standard surface-enhanced Raman spectroscopy

Determination of Chlorpyrifos in Human Blood by Gas Chromatography-Mass Spectrometry

Determination of Chlorzoxazone in Human Plasma by RP-HPLC

Toxicokinetics of Paraquat in Rabbits

Determination of Chlorzoxazone and Its Metabolite in Human Plasma by HPLC-MS

Determination of paracetamol in human plasma by solid phase extracted-HPLC method

Measurement of Paraquat in Urine by a Novel Two-Dimensional Liquid Chromatographic System

Simultaneous determination of diquat, paraquat, glufosinate, and glyphosate in plasma by liquid chromatography/tandem mass spectrometry: from method development to clinical application

Progress in Determination Method of Paraquat in Biological Samples

[Determination of paraquat and diquat residues in urine samples based on solid-phase extraction and ultra performance liquid chromatography-high resolution mass spectrometry]

Supramolecular Solvent-Based Liquid Phase Microextraction Combined with Ion-Pairing Reversed-Phase HPLC for the Determination of Quats in Vegetable Samples

Determination of Amodiaquine in Human Plasma by High Performance Liquid Chromatography

HPLC-MS/MS Determination of Quetiapine in Human Plasma

Determination of Pralidoxime Iodide in Human Plasma and Urine by Reversed - Phase High Performance Liquid Chromatography

Determination of puerarin in plasma by HPLC